β-Catenin (encoded by CTNNB1) is upregulated in the tumor tissues of patients with PC and induces carcinogenesis, invasiveness, metastasis, angiogenesis, and therapeutic sensitivity of PC cells and tumors [70–74]. Here, CTNNB1 is linked to neoplasm.